Cardio Diagnostics Holdings is trading at $1.98 (+8.20%) as anticipation builds around its expected August 13 earnings announcement.
- The stock rose 7.02% on August 11 and 7.83% on August 7.
- Its August 7 Q2 release reported $5,360 in sales and a $1.5 million net loss.
- Broader risk-on sentiment, led by a 0.89% Nasdaq gain, may also be supporting pre-market activity.